{"transactions":[{"id":1482952,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T20:45:51.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":69100,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share (the \"Common Stock\") for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":15.92,"underlying":"Common Stock","underlying_shares":69100},"source":{"system":"sec-edgar","filing":"0000950170-24-072214","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000095017024072214/ownership.xml","form_type":"4"}},{"id":1482951,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T20:45:51.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65900,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share (the \"Common Stock\") for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":13.42,"underlying":"Common Stock","underlying_shares":65900},"source":{"system":"sec-edgar","filing":"0000950170-24-072214","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000095017024072214/ownership.xml","form_type":"4"}},{"id":1482950,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-06-11T20:45:51.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":184088,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share (the \"Common Stock\") for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-072214","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000095017024072214/ownership.xml","form_type":"4"}},{"id":1482949,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-06-11T20:45:51.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":25913,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") previously granted to the Reporting Person subject to performance-based vesting conditions, for which the performance conditions associated with such RSUs had not yet occurred."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") previously granted to the Reporting Person subject to performance-based vesting conditions, for which the performance conditions associated with such RSUs had not yet occurred."}],"balance_after":184088,"source":{"system":"sec-edgar","filing":"0000950170-24-072214","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000095017024072214/ownership.xml","form_type":"4"}},{"id":1632586,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-20T16:05:20.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":69100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in equal monthly installments over four years, beginning on March 15, 2024."}],"balance_after":69100,"derivative":{"exercise_price":15.92,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":69100},"source":{"system":"sec-edgar","filing":"0000950170-24-017089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000095017024017089/ownership.xml","form_type":"4"}},{"id":1632585,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-20T16:05:20.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":17275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person was awarded 17,275 Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in three equal installments on each of February 15, 2025, February 15, 2026 and February 15, 2027."}],"balance_after":158175,"source":{"system":"sec-edgar","filing":"0000950170-24-017089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000095017024017089/ownership.xml","form_type":"4"}},{"id":1776868,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-19T16:05:32.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":65900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. 25% of the shares underlying the option shall vest on September 15, 2024, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":65900,"derivative":{"exercise_price":13.42,"expiration_date":"2033-09-14","underlying":"Common Stock","underlying_shares":65900},"source":{"system":"sec-edgar","filing":"0001209191-23-049907","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919123049907/doc4.xml","form_type":"4"}},{"id":1776867,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-09-19T16:05:32.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person was awarded 75,000 RSUs. These RSUs will vest in two equal annual installments on each of September 15, 2024 and September 15, 2025."}],"balance_after":140900,"source":{"system":"sec-edgar","filing":"0001209191-23-049907","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919123049907/doc4.xml","form_type":"4"}},{"id":1776866,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-09-19T16:05:32.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":65900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person was awarded 65,900 Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. These RSUs shall vest in three equal annual installments on each of September 15, 2024, September 15, 2025 and September 15, 2026."}],"balance_after":65900,"source":{"system":"sec-edgar","filing":"0001209191-23-049907","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919123049907/doc4.xml","form_type":"4"}},{"id":1828198,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-07-18T20:00:18.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":16896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":16896,"derivative":{"exercise_price":61.76,"expiration_date":"2033-07-13","underlying":"Common Stock","underlying_shares":16896},"source":{"system":"sec-edgar","filing":"0001209191-23-042553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123042553/doc4.xml","form_type":"4"}},{"id":1828197,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-07-18T20:00:18.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":8056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years, subject to Dashyant Dhanak's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including the July 14, 2023 RSU Grant, this includes an aggregate of 53,279 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested."}],"balance_after":58968,"source":{"system":"sec-edgar","filing":"0001209191-23-042553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123042553/doc4.xml","form_type":"4"}},{"id":1834525,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-07-06T20:00:17.000Z","date":"2023-07-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":6044,"price":62.08,"value":375211.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 25,082 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested."}],"balance_after":50912,"source":{"system":"sec-edgar","filing":"0001209191-23-041504","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123041504/doc4.xml","form_type":"4"}},{"id":2004954,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2023-02-21T21:00:46.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":3693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":0,"derivative":{"exercise_price":65.42,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":3693},"source":{"system":"sec-edgar","filing":"0001209191-23-011110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123011110/doc4.xml","form_type":"4"}},{"id":2004953,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-21T21:00:46.000Z","date":"2023-02-16","kind":"exercise","acquired":true,"shares":3693,"price":65.42,"value":241596.06,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This includes an aggregate of 41,531 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":56956,"source":{"system":"sec-edgar","filing":"0001209191-23-011110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123011110/doc4.xml","form_type":"4"}},{"id":2042812,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-30T21:00:16.000Z","date":"2023-01-26","kind":"sale","acquired":false,"shares":2419,"price":85,"value":205615.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 41,531 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":53263,"source":{"system":"sec-edgar","filing":"0001209191-23-005451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123005451/doc4.xml","form_type":"4"}},{"id":2048026,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-24T21:00:26.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":16128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Beginning January 20, 2023, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2023 and the remainder vesting monthly over three years."}],"balance_after":16128,"derivative":{"exercise_price":83.2,"expiration_date":"2033-01-19","underlying":"Common Stock","underlying_shares":16128},"source":{"system":"sec-edgar","filing":"0001209191-23-004558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123004558/doc4.xml","form_type":"4"}},{"id":2048025,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-24T21:00:26.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":4980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying performance shares earned upon the achievement of performance criteria determined to be satisfied on January 20, 2023.  The earned shares will vest on the third anniversary of the July 2, 2020 grant date, subject to the Reporting Persons continued service with the Issuer.  Each performance share represents the right to receive one or more shares of common stock based on, and subject to, the achievement of specified financial and development performance criteria determined by the Issuers Compensation Committee in January 2020 as set forth in the Performance Share Award Agreement.  The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 175% of the number of performance shares awarded."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 41,531 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.  The aggregate amount also includes the additional Performance Stock Units earned on January 20, 2023."}],"balance_after":55682,"source":{"system":"sec-edgar","filing":"0001209191-23-004558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123004558/doc4.xml","form_type":"4"}},{"id":2088755,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-12-13T21:00:35.000Z","date":"2022-12-12","kind":"tax_withholding","acquired":false,"shares":533,"price":82.36,"value":43897.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 36,551 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested."}],"balance_after":50702,"source":{"system":"sec-edgar","filing":"0001209191-22-060896","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122060896/doc4.xml","form_type":"4"}},{"id":2213165,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-06T20:06:00.000Z","date":"2022-07-02","kind":"grant","acquired":true,"shares":15277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Beginning July 2, 2022, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":15277,"derivative":{"exercise_price":77.67,"expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":15277},"source":{"system":"sec-edgar","filing":"0001209191-22-041062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122041062/doc4.xml","form_type":"4"}},{"id":2213164,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-07-06T20:06:00.000Z","date":"2022-07-05","kind":"tax_withholding","acquired":false,"shares":2181,"price":79.25,"value":172844.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Including the July 2, 2022 RSU Grant, this includes an aggregate of 26,997 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested."}],"balance_after":51235,"source":{"system":"sec-edgar","filing":"0001209191-22-041062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122041062/doc4.xml","form_type":"4"}},{"id":2213163,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-07-06T20:06:00.000Z","date":"2022-07-02","kind":"grant","acquired":true,"shares":11274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years, subject to Dashyant Dhanak's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":53416,"source":{"system":"sec-edgar","filing":"0001209191-22-041062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122041062/doc4.xml","form_type":"4"}},{"id":2429245,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-21T21:13:02.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":15054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning January 19, 2022, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2022 and the remainder vesting monthly over three years."}],"balance_after":15054,"derivative":{"exercise_price":74.78,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":15054},"source":{"system":"sec-edgar","filing":"0001209191-22-004398","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122004398/doc4.xml","form_type":"4"}},{"id":2445781,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-05T21:06:56.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":8678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 100% on December 31, 2025, subject to Dashyant Dhanak's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 34,035 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":42142,"source":{"system":"sec-edgar","filing":"0001209191-22-001631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122001631/doc4.xml","form_type":"4"}},{"id":2474322,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-14T21:23:25.000Z","date":"2021-12-10","kind":"tax_withholding","acquired":false,"shares":533,"price":65.4,"value":34858.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 25,357 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested."}],"balance_after":33464,"source":{"system":"sec-edgar","filing":"0001209191-21-069427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121069427/doc4.xml","form_type":"4"}},{"id":2499429,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-23T21:07:21.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":2355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock underlying performance shares earned upon the interim achievement of performance criteria determined to be satisfied on November 19, 2021. The earned shares will vest on the third anniversary of the July 2, 2021 grant date, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, the achievement of specified financial and development performance criteria determined by the Issuers Compensation Committee in February 2021 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 150% of the number of performance shares awarded."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Including the Performance Stock Units earned on November 19, 2021, this includes an aggregate of 27,077 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested."}],"balance_after":33997,"source":{"system":"sec-edgar","filing":"0001209191-21-066394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121066394/doc4.xml","form_type":"4"}},{"id":2499428,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-23T21:07:21.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying performance shares earned upon the interim achievement of performance criteria determined to be satisfied on November 19, 2021.  The earned shares will vest on the third anniversary of the July 2, 2020 grant date, subject to the Reporting Persons continued service with the Issuer.  Each performance share represents the right to receive one or more shares of common stock based on, and subject to, the achievement of specified financial and development performance criteria determined by the Issuers Compensation Committee in January 2020 as set forth in the Performance Share Award Agreement.  The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 175% of the number of performance shares awarded."}],"balance_after":31642,"source":{"system":"sec-edgar","filing":"0001209191-21-066394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121066394/doc4.xml","form_type":"4"}},{"id":2553178,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-04T20:41:25.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":389,"price":68.67,"value":26712.63,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 24,343 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":31263,"source":{"system":"sec-edgar","filing":"0001209191-21-059017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121059017/doc4.xml","form_type":"4"}},{"id":2580361,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-03T11:40:32.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":388,"price":76.71,"value":29763.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 24,343 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":31652,"source":{"system":"sec-edgar","filing":"0001209191-21-054617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121054617/doc4.xml","form_type":"4"}},{"id":2616002,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-04T20:16:19.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":389,"price":77.49,"value":30143.61,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 24,343 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":32040,"source":{"system":"sec-edgar","filing":"0001209191-21-049611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121049611/doc4.xml","form_type":"4"}},{"id":2640071,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-07-07T20:09:28.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":15054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Beginning July 2, 2021, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":15054,"derivative":{"exercise_price":83.58,"expiration_date":"2031-07-01","underlying":"Common Stock","underlying_shares":15054},"source":{"system":"sec-edgar","filing":"0001209191-21-045780","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121045780/doc4.xml","form_type":"4"}},{"id":2640070,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-07T20:09:28.000Z","date":"2021-07-02","kind":"tax_withholding","acquired":false,"shares":1573,"price":83.58,"value":131471.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Including the July 2, 2021 Restricted Stock Unit Grant, this includes an aggregate of 24,343 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":32429,"source":{"system":"sec-edgar","filing":"0001209191-21-045780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121045780/doc4.xml","form_type":"4"}},{"id":2640069,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-07T20:09:28.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":7853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years, subject to Dashyant Dhanak's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":34002,"source":{"system":"sec-edgar","filing":"0001209191-21-045780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121045780/doc4.xml","form_type":"4"}},{"id":2646199,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-02T23:15:24.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":396,"price":84.09,"value":33299.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 21,565 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":26149,"source":{"system":"sec-edgar","filing":"0001209191-21-045189","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121045189/doc4.xml","form_type":"4"}},{"id":2670904,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-14T20:28:17.000Z","date":"2021-06-10","kind":"exercise","acquired":false,"shares":3845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":26914,"derivative":{"exercise_price":65.42,"exercise_date":"2021-06-10","expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":3845},"source":{"system":"sec-edgar","filing":"0001209191-21-040231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121040231/doc4.xml","form_type":"4"}},{"id":2670903,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-14T20:28:17.000Z","date":"2021-06-10","kind":"sale","acquired":false,"shares":3845,"price":87,"value":334515.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 21,565 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":26545,"source":{"system":"sec-edgar","filing":"0001209191-21-040231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121040231/doc4.xml","form_type":"4"}},{"id":2670902,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-14T20:28:17.000Z","date":"2021-06-10","kind":"exercise","acquired":true,"shares":3845,"price":65.42,"value":251539.9,"ownership":{"direct":true},"balance_after":30390,"source":{"system":"sec-edgar","filing":"0001209191-21-040231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121040231/doc4.xml","form_type":"4"}},{"id":2684687,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-03T20:42:35.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":395,"price":84.13,"value":33231.35,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 21,565 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":26545,"source":{"system":"sec-edgar","filing":"0001209191-21-037695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121037695/doc4.xml","form_type":"4"}},{"id":2728309,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-05-05T20:09:04.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":396,"price":85.4,"value":33818.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 21,565 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":26940,"source":{"system":"sec-edgar","filing":"0001209191-21-030291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121030291/doc4.xml","form_type":"4"}},{"id":2759325,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-04-05T20:25:39.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":396,"price":81.57,"value":32301.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 21,565 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":27336,"source":{"system":"sec-edgar","filing":"0001209191-21-025137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121025137/doc4.xml","form_type":"4"}},{"id":2816466,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-03T21:28:10.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":395,"price":79.73,"value":31493.35,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 21,565 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":27732,"source":{"system":"sec-edgar","filing":"0001209191-21-016865","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121016865/doc4.xml","form_type":"4"}},{"id":2883353,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-02-03T21:27:38.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":30759,"derivative":{"exercise_price":65.42,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":961},"source":{"system":"sec-edgar","filing":"0001209191-21-007253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121007253/doc4.xml","form_type":"4"}},{"id":2883352,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-03T21:27:38.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":395,"price":90,"value":35550.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 21,565 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":28127,"source":{"system":"sec-edgar","filing":"0001209191-21-007253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121007253/doc4.xml","form_type":"4"}},{"id":2883351,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-03T21:27:38.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":961,"price":90,"value":86490.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."}],"balance_after":28522,"source":{"system":"sec-edgar","filing":"0001209191-21-007253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121007253/doc4.xml","form_type":"4"}},{"id":2883350,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-03T21:27:38.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":961,"price":65.42,"value":62868.62,"ownership":{"direct":true},"balance_after":29483,"source":{"system":"sec-edgar","filing":"0001209191-21-007253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121007253/doc4.xml","form_type":"4"}},{"id":2903349,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-20T21:25:39.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":12743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning January 15, 2021, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2021 and the remainder vesting monthly over three years."}],"balance_after":12743,"derivative":{"exercise_price":90.56,"expiration_date":"2031-01-14","underlying":"Common Stock","underlying_shares":12743},"source":{"system":"sec-edgar","filing":"0001209191-21-004295","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121004295/doc4.xml","form_type":"4"}},{"id":2947443,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-14T21:19:05.000Z","date":"2020-12-10","kind":"tax_withholding","acquired":false,"shares":720,"price":82.05,"value":59076.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 21,565 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested."}],"balance_after":28522,"source":{"system":"sec-edgar","filing":"0001209191-20-063210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120063210/doc4.xml","form_type":"4"}},{"id":2976311,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-11-18T21:16:28.000Z","date":"2020-11-16","kind":"grant","acquired":true,"shares":1232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying performance shares earned upon the interim achievement of performance criteria determined to be satisfied on November 16, 2020.  The earned shares will vest on the third anniversary of the July 2, 2020 grant date, subject to the Reporting Persons continued service with the Issuer.  Each performance share represents the right to receive one or more shares of common stock based on, and subject to, the achievement of specified financial and development performance criteria determined by the Issuers Compensation Committee in January 2020 as set forth in the Performance Share Award Agreement.  The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 175% of the number of performance shares awarded."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including the Performance Stock Units earned on November 16, 2020, this includes an aggregate of 23,284 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested."}],"balance_after":29242,"source":{"system":"sec-edgar","filing":"0001209191-20-059070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120059070/doc4.xml","form_type":"4"}},{"id":2987312,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-11-10T21:26:54.000Z","date":"2020-11-06","kind":"exercise","acquired":false,"shares":961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":31720,"derivative":{"exercise_price":65.42,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":961},"source":{"system":"sec-edgar","filing":"0001209191-20-057648","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120057648/doc4.xml","form_type":"4"}},{"id":2987311,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-11-10T21:26:54.000Z","date":"2020-11-06","kind":"sale","acquired":false,"shares":961,"price":85.17,"value":81848.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 22,052 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":28010,"source":{"system":"sec-edgar","filing":"0001209191-20-057648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120057648/doc4.xml","form_type":"4"}},{"id":2987310,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-11-10T21:26:54.000Z","date":"2020-11-06","kind":"exercise","acquired":true,"shares":961,"price":65.42,"value":62868.62,"ownership":{"direct":true},"balance_after":28971,"source":{"system":"sec-edgar","filing":"0001209191-20-057648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120057648/doc4.xml","form_type":"4"}},{"id":3010358,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-10-08T20:21:45.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":32681,"derivative":{"exercise_price":65.42,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":961},"source":{"system":"sec-edgar","filing":"0001209191-20-054279","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120054279/doc4.xml","form_type":"4"}},{"id":3010357,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-10-08T20:21:45.000Z","date":"2020-10-06","kind":"sale","acquired":false,"shares":961,"price":91.97,"value":88383.17,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 22,052 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":28010,"source":{"system":"sec-edgar","filing":"0001209191-20-054279","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120054279/doc4.xml","form_type":"4"}},{"id":3010356,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-10-08T20:21:45.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":961,"price":65.42,"value":62868.62,"ownership":{"direct":true},"balance_after":28971,"source":{"system":"sec-edgar","filing":"0001209191-20-054279","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120054279/doc4.xml","form_type":"4"}},{"id":3034834,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-09-10T20:21:35.000Z","date":"2020-09-08","kind":"exercise","acquired":false,"shares":961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":33642,"derivative":{"exercise_price":65.42,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":961},"source":{"system":"sec-edgar","filing":"0001209191-20-049959","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120049959/doc4.xml","form_type":"4"}},{"id":3034833,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-09-10T20:21:35.000Z","date":"2020-09-08","kind":"sale","acquired":false,"shares":961,"price":88.94,"value":85471.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 22,052 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":28010,"source":{"system":"sec-edgar","filing":"0001209191-20-049959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120049959/doc4.xml","form_type":"4"}},{"id":3034832,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-09-10T20:21:35.000Z","date":"2020-09-08","kind":"exercise","acquired":true,"shares":961,"price":65.42,"value":62868.62,"ownership":{"direct":true},"balance_after":28971,"source":{"system":"sec-edgar","filing":"0001209191-20-049959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120049959/doc4.xml","form_type":"4"}},{"id":3064014,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-08-10T20:20:57.000Z","date":"2020-08-06","kind":"exercise","acquired":false,"shares":961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":34603,"derivative":{"exercise_price":65.42,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":961},"source":{"system":"sec-edgar","filing":"0001209191-20-045938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120045938/doc4.xml","form_type":"4"}},{"id":3064013,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-10T20:20:57.000Z","date":"2020-08-06","kind":"sale","acquired":false,"shares":961,"price":97.8,"value":93985.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 22,052 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":28010,"source":{"system":"sec-edgar","filing":"0001209191-20-045938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120045938/doc4.xml","form_type":"4"}},{"id":3064012,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-10T20:20:57.000Z","date":"2020-08-06","kind":"exercise","acquired":true,"shares":961,"price":65.42,"value":62868.62,"ownership":{"direct":true},"balance_after":28971,"source":{"system":"sec-edgar","filing":"0001209191-20-045938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120045938/doc4.xml","form_type":"4"}},{"id":3083907,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2020-07-14T20:31:43.000Z","date":"2020-07-13","kind":"exercise","acquired":false,"shares":2419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":0,"derivative":{"exercise_price":65.42,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":2419},"source":{"system":"sec-edgar","filing":"0001209191-20-042366","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120042366/doc4.xml","form_type":"4"}},{"id":3083906,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-14T20:31:43.000Z","date":"2020-07-13","kind":"exercise","acquired":true,"shares":2419,"price":65.42,"value":158250.98,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This includes an aggregate of 22,052 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":28010,"source":{"system":"sec-edgar","filing":"0001209191-20-042366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120042366/doc4.xml","form_type":"4"}},{"id":3087803,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-07-07T23:13:36.000Z","date":"2020-07-06","kind":"exercise","acquired":false,"shares":961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":35564,"derivative":{"exercise_price":65.42,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":961},"source":{"system":"sec-edgar","filing":"0001209191-20-041549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120041549/doc4.xml","form_type":"4"}},{"id":3087802,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-07-07T23:13:36.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":12743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Beginning July 2, 2020, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":12743,"derivative":{"exercise_price":106.47,"expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":12743},"source":{"system":"sec-edgar","filing":"0001209191-20-041549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120041549/doc4.xml","form_type":"4"}},{"id":3087801,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-07T23:13:36.000Z","date":"2020-07-06","kind":"sale","acquired":false,"shares":961,"price":106.58,"value":102423.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 22,052 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested."}],"balance_after":25591,"source":{"system":"sec-edgar","filing":"0001209191-20-041549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120041549/doc4.xml","form_type":"4"}},{"id":3087800,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-07T23:13:36.000Z","date":"2020-07-06","kind":"exercise","acquired":true,"shares":961,"price":65.42,"value":62868.62,"ownership":{"direct":true},"balance_after":26552,"source":{"system":"sec-edgar","filing":"0001209191-20-041549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120041549/doc4.xml","form_type":"4"}},{"id":3087799,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-07T23:13:36.000Z","date":"2020-07-02","kind":"tax_withholding","acquired":false,"shares":1057,"price":106.47,"value":112538.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock."}],"balance_after":25591,"source":{"system":"sec-edgar","filing":"0001209191-20-041549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120041549/doc4.xml","form_type":"4"}},{"id":3087798,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-07T23:13:36.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":6661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years, subject to Dashyant Dhanak's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":26648,"source":{"system":"sec-edgar","filing":"0001209191-20-041549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120041549/doc4.xml","form_type":"4"}},{"id":3115378,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-10T20:34:48.000Z","date":"2020-06-08","kind":"exercise","acquired":false,"shares":961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25.00% vesting on December 10, 2019 and the remainder vesting monthly over three years."}],"balance_after":36525,"derivative":{"exercise_price":65.42,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":961},"source":{"system":"sec-edgar","filing":"0001209191-20-035524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120035524/doc4.xml","form_type":"4"}},{"id":3115377,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-06-10T20:34:48.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":961,"price":91.87,"value":88287.07,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 18,801 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested."}],"balance_after":19987,"source":{"system":"sec-edgar","filing":"0001209191-20-035524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120035524/doc4.xml","form_type":"4"}},{"id":3115376,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-06-10T20:34:48.000Z","date":"2020-06-08","kind":"exercise","acquired":true,"shares":961,"price":65.42,"value":62868.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."}],"balance_after":20948,"source":{"system":"sec-edgar","filing":"0001209191-20-035524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120035524/doc4.xml","form_type":"4"}},{"id":3157128,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-08T20:53:04.000Z","date":"2020-05-06","kind":"exercise","acquired":false,"shares":961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25.00% vesting on December 10, 2019 and the remainder vesting monthly over three years."}],"balance_after":37486,"derivative":{"exercise_price":65.42,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":961},"source":{"system":"sec-edgar","filing":"0001209191-20-027959","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120027959/doc4.xml","form_type":"4"}},{"id":3157127,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-05-08T20:53:04.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":961,"price":96.84,"value":93063.24,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 18,801 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested."}],"balance_after":19987,"source":{"system":"sec-edgar","filing":"0001209191-20-027959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120027959/doc4.xml","form_type":"4"}},{"id":3157126,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-05-08T20:53:04.000Z","date":"2020-05-06","kind":"exercise","acquired":true,"shares":961,"price":65.42,"value":62868.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."}],"balance_after":20948,"source":{"system":"sec-edgar","filing":"0001209191-20-027959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120027959/doc4.xml","form_type":"4"}},{"id":3180029,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-04-08T20:35:27.000Z","date":"2020-04-06","kind":"exercise","acquired":false,"shares":3844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25.00% vesting on December 10, 2019 and the remainder vesting monthly over three years."}],"balance_after":38447,"derivative":{"exercise_price":65.42,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":3844},"source":{"system":"sec-edgar","filing":"0001209191-20-023920","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120023920/doc4.xml","form_type":"4"}},{"id":3180028,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-04-08T20:35:27.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":3844,"price":85,"value":326740.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 18,801 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested."}],"balance_after":19987,"source":{"system":"sec-edgar","filing":"0001209191-20-023920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120023920/doc4.xml","form_type":"4"}},{"id":3180027,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-04-08T20:35:27.000Z","date":"2020-04-06","kind":"exercise","acquired":true,"shares":3844,"price":65.42,"value":251474.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."}],"balance_after":23831,"source":{"system":"sec-edgar","filing":"0001209191-20-023920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120023920/doc4.xml","form_type":"4"}},{"id":3268272,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-02-18T21:02:19.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":6881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying performance shares earned upon the achievement of performance criteria determined to be satisfied on February 13, 2020. The performance shares vest 25% annually over four years from the grant date of July 2, 2019, subject to the Reporting Person's continued service with the Issuer through the applicable vesting dates. Each performance share initially represented the right to receive one or more shares of common stock based on, and subject to, the achievement of revenue-based performance criteria determined by the Issuer's Compensation Committee in February 2020 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person was entitled to receive ranged from 0% to 125% of the number of performance shares awarded, and the performance criteria was achieved at the 101.80% level."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including the Performance Stock Units earned on February 13, 2020, this includes an aggregate of 18,801 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested."}],"balance_after":19987,"source":{"system":"sec-edgar","filing":"0001209191-20-010034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120010034/doc4.xml","form_type":"4"}},{"id":3305543,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-22T21:11:42.000Z","date":"2020-01-17","kind":"grant","acquired":true,"shares":16428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning January 17, 2020, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2020 and the remainder vesting monthly over three years."}],"balance_after":16428,"derivative":{"exercise_price":80.5,"expiration_date":"2030-01-16","underlying":"Common Stock","underlying_shares":16428},"source":{"system":"sec-edgar","filing":"0001209191-20-004448","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120004448/doc4.xml","form_type":"4"}},{"id":3344277,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-12-12T21:36:41.000Z","date":"2019-12-10","kind":"tax_withholding","acquired":false,"shares":533,"price":95.72,"value":51018.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 11,920 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":13106,"source":{"system":"sec-edgar","filing":"0001209191-19-060228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119060228/doc4.xml","form_type":"4"}},{"id":3469382,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-07-03T18:31:44.000Z","date":"2019-07-02","kind":"grant","acquired":true,"shares":16428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Beginning July 2, 2019, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":16428,"derivative":{"exercise_price":85.01,"expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":16428},"source":{"system":"sec-edgar","filing":"0001209191-19-040882","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119040882/doc4.xml","form_type":"4"}},{"id":3469381,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-07-03T18:31:44.000Z","date":"2019-07-02","kind":"grant","acquired":true,"shares":6761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years, subject to Dashyant Dhanak's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including the July 2, 2019 Restricted Stock Unit Grant, this includes an aggregate of 13,639 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":13639,"source":{"system":"sec-edgar","filing":"0001209191-19-040882","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119040882/doc4.xml","form_type":"4"}},{"id":3734726,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-12-12T21:10:04.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":48403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":48403,"derivative":{"exercise_price":65.42,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":48403},"source":{"system":"sec-edgar","filing":"0001209191-18-062223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919118062223/doc4.xml","form_type":"4"}},{"id":3734725,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":90037,"kind":"person","name":"Dhanak Dashyant","position":1,"cik":"0001760682","reported_name":"Dhanak Dashyant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-12-12T21:10:04.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":6878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years, subject to Dr. Dashyant Dhanak's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":6878,"source":{"system":"sec-edgar","filing":"0001209191-18-062223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919118062223/doc4.xml","form_type":"4"}}]}